MPL Stock Overview
Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia.
Medibank Private Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$3.49|
|52 Week High||AU$3.74|
|52 Week Low||AU$2.70|
|1 Month Change||3.25%|
|3 Month Change||1.75%|
|1 Year Change||19.11%|
|3 Year Change||32.70%|
|5 Year Change||29.74%|
|Change since IPO||63.08%|
Recent News & Updates
Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069
Medibank Private Limited's ( ASX:MPL ) dividend will be increasing to AU$0.069 on 30th of September. The announced...
|MPL||AU Insurance||AU Market|
Return vs Industry: MPL exceeded the Australian Insurance industry which returned 17.6% over the past year.
Return vs Market: MPL exceeded the Australian Market which returned 10.4% over the past year.
|MPL Average Weekly Movement||3.3%|
|Insurance Industry Average Movement||3.3%|
|Market Average Movement||8.4%|
|10% most volatile stocks in AU Market||15.2%|
|10% least volatile stocks in AU Market||3.6%|
Stable Share Price: MPL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: MPL's weekly volatility (3%) has been stable over the past year.
About the Company
Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia. The company operates through two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy.
Medibank Private Fundamentals Summary
|MPL fundamental statistics|
Is MPL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MPL income statement (TTM)|
|Cost of Revenue||AU$5.56b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Feb 24, 2022
|Earnings per share (EPS)||0.16|
|Net Profit Margin||6.27%|
How did MPL perform over the long term?See historical performance and comparison
3.6%Current Dividend Yield
Is Medibank Private undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MPL (A$3.49) is trading below our estimate of fair value (A$4.22)
Significantly Below Fair Value: MPL is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: MPL is good value based on its PE Ratio (21.8x) compared to the Australian Insurance industry average (30.7x).
PE vs Market: MPL is poor value based on its PE Ratio (21.8x) compared to the Australian market (19.3x).
Price to Earnings Growth Ratio
PEG Ratio: MPL is poor value based on its PEG Ratio (5.4x)
Price to Book Ratio
PB vs Industry: MPL is overvalued based on its PB Ratio (5x) compared to the AU Insurance industry average (4.1x).
How is Medibank Private forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MPL's forecast earnings growth (4% per year) is above the savings rate (1.9%).
Earnings vs Market: MPL's earnings (4% per year) are forecast to grow slower than the Australian market (11.3% per year).
High Growth Earnings: MPL's earnings are forecast to grow, but not significantly.
Revenue vs Market: MPL's revenue (4.1% per year) is forecast to grow slower than the Australian market (4.9% per year).
High Growth Revenue: MPL's revenue (4.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MPL's Return on Equity is forecast to be high in 3 years time (22.9%)
How has Medibank Private performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MPL has high quality earnings.
Growing Profit Margin: MPL's current net profit margins (6.3%) are higher than last year (4.7%).
Past Earnings Growth Analysis
Earnings Trend: MPL's earnings have declined by 3.2% per year over the past 5 years.
Accelerating Growth: MPL's earnings growth over the past year (39.8%) exceeds its 5-year average (-3.2% per year).
Earnings vs Industry: MPL earnings growth over the past year (39.8%) underperformed the Insurance industry 57.5%.
Return on Equity
High ROE: MPL's Return on Equity (23.1%) is considered high.
How is Medibank Private's financial position?
Financial Position Analysis
Short Term Liabilities: MPL's short term assets (A$3.2B) exceed its short term liabilities (A$1.9B).
Long Term Liabilities: MPL's short term assets (A$3.2B) exceed its long term liabilities (A$162.4M).
Debt to Equity History and Analysis
Debt Level: MPL is debt free.
Reducing Debt: MPL has not had any debt for past 5 years.
Debt Coverage: MPL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MPL has no debt, therefore coverage of interest payments is not a concern.
What is Medibank Private current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: MPL's dividend (3.64%) is higher than the bottom 25% of dividend payers in the Australian market (2.18%).
High Dividend: MPL's dividend (3.64%) is low compared to the top 25% of dividend payers in the Australian market (5.39%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, MPL has been paying a dividend for less than 10 years.
Growing Dividend: MPL's dividend payments have increased, but the company has only paid a dividend for 6 years.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (79.3%), MPL's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: MPL's dividends in 3 years are forecast to be covered by earnings (83.3% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David Koczkar (48 yo)
Mr. David Koczkar, BCom, PG Dip Finance, MAICD, serves as Managing Director, Director and Chief Executive Officer at Medibank Private Limited since May 17, 2021 and served as Group Executive and Chief Cust...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD1.53M) is below average for companies of similar size in the Australian market ($USD2.36M).
Compensation vs Earnings: David's compensation has increased by more than 20% in the past year.
Experienced Management: MPL's management team is seasoned and experienced (5 years average tenure).
Experienced Board: MPL's board of directors are considered experienced (6.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Medibank Private Limited's employee growth, exchange listings and data sources
- Name: Medibank Private Limited
- Ticker: MPL
- Exchange: ASX
- Founded: 1976
- Industry: Life and Health Insurance
- Sector: Insurance
- Implied Market Cap: AU$9.614b
- Shares outstanding: 2.75b
- Website: https://www.medibank.com.au
Number of Employees
- Medibank Private Limited
- 720 Bourke Street
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/17 16:18|
|End of Day Share Price||2022/01/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.